AzTrials
AzTrials

Topical FluorideNCT07091890

Effects of Topical Fluoride in Orthodontic Patients

A study testing Fluoride gel and Fluoride varnish in people with Topical Fluoride and Orthodontic Patients, run by Universita di Verona at 1 site in Italy.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

This study was born from the need to improve caries prevention in orthodontic patients, a group particularly at risk. Fixed orthodontic appliances make daily oral hygiene more difficult, leading to increased plaque accumulation and the proliferation of cariogenic bacteria such as Streptococcus mutans and, more… Read more about this study

Who is it for?
Ages 6 to 20 yearsHealthy volunteers can take part
What is being tested?
Fluoride gel and Fluoride varnish
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteItaly
Study dates
16 Nov 2023to Nov 2025
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 20 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • 1 < DMFT < n-1 (n= number of teeth present in the oral cavity)
  • age between 8 and 17 years
  • patient wearing fixed orthodontic appliances

Who cannot join

  • DMFT = 0 *; professional topical fluoride prophylaxis session carried out in the last 3 months
  • patient not wearing fixed orthodontic appliances
  • orthodontic treatment already completed or not started * DMFT refers to a caries prevalence index related to the presence of Decayed, Missing, Filled Teeth due to caries (Decayed, Missing, Filled Teeth).

Trial locations and contacts

1 site in 1 country.

Italy1 site
  • Integrated University Hospital Company Verona

    Verona, 37134

Other trials in Italy

About this study

Official title: Microbiology and Clinical Efficacy of Professional Topical Fluoride on Streptococcus Mutans and Selemonas Sputigena in Orthodontic Patients: a Randomized Clinical Trial

This study was born from the need to improve caries prevention in orthodontic patients, a group particularly at risk. Fixed orthodontic appliances make daily oral hygiene more difficult, leading to increased plaque accumulation and the proliferation of cariogenic bacteria such as Streptococcus mutans and, more recently, Selenomonas sputigena. Although the latter does not cause cavities on its own, it enhances the action of Streptococcus mutans, making the caries process more aggressive.

The aim of the research was to evaluate the effectiveness of two different types of professional topical fluoride-gel and varnish-in reducing the presence of these bacteria and improving certain clinical parameters, such as salivary pH, the DMFT index (which measures decayed, missing, and filled teeth), and the Plaque Control Record (PCR%).

Read more

The study involved 45 patients, all between 8 and 17 years old and wearing fixed orthodontic appliances. They were divided into three groups: one received fluoride gel, another received fluoride varnish, and the third group underwent only a professional oral hygiene session, without any fluoride application. All patients were evaluated at the beginning of the study (T0) and again after four months (T1), both clinically and microbiologically, through saliva and plaque analysis.

The results showed that in the fluoride-treated groups-especially the varnish group-there was a significant reduction in plaque, an improvement in salivary pH (mainly in the gel group), and a decrease in the presence of S. mutans and S. sputigena. Furthermore, there was a reduction in oral Streptococci and Lactobacilli levels in the treated groups, whereas these levels increased in the control group. Interestingly, although not all differences were statistically significant, the improvements observed in the treatment groups suggest a clinically relevant benefit of topical fluoride, especially in varnish form.

In conclusion, professional application of fluoride-whether in gel or varnish form-proved effective in counteracting key bacteria responsible for dental caries in orthodontic patients and in improving several relevant clinical parameters. This confirms the importance of combining professional oral hygiene with specific fluoride treatments in patients wearing orthodontic appliances.

Being tested
Fluoride gel, Fluoride varnish

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Fluoride gelDevice

    After non-surgical therapy, 6-8 g of a gel containing 12,500 ppm of fluoride was applied for 4 min using a disposable tray appropriately sized for the patient's mouth. As per the guidelines, the patient was asked to briefly rinse their mouth with water. The aim was to remineralize the dental enamel to make it less susceptible to acid attacks caused by low salivary pH and the byproducts of bacterial metabolism

  • Fluoride varnishDevice

    After non-surgical therapy, a fluoride varnish containing 7,700 ppm of fluoride in a homogeneous solution was evenly distributed over the dental surfaces using a micro-brush. Patients were instructed to spit out excess saliva but not to rinse their mouth with water, and to refrain from eating or drinking for at least 60 min afterward. After drying, the varnish formed a fluoride-rich layer on the enamel, increasing the concentration by up to four times. Despite the high concentration of fluoride, the resin component of the varnish allowed for a slow, controlled release of fluoride over time, thus preventing its immediate loss and minimizing the amount ingested by the patient. The purpose was to prevent mineral loss from the enamel and promote its restoration, making the dental tissue more resistant to the acidic pH of saliva caused by the production of organic acids through bacterial metabolism.

Study groups in NCT07091890
Study groupRoleWhat they receive
Professional oral hygiene session and a topical fluoride prophylaxis treatment with gelExperimentalNot described
Receives: Device: Fluoride gel
Professional oral hygiene session and a topical fluoride prophylaxis treatment with varnishExperimentalNot described
Receives: Device: Fluoride varnish
Professional oral hygiene session aloneNo interventionAll patients underwent a professional oral hygiene session to remove bacterial plaque and calculus from the tooth surfaces. Bacterial plaque was removed using a supragingival air-polishing device that dispersed glycine powder. When calcified residues were present, a piezoelectric ultrasonic scaler with either a supragingival insert, perio-slim periodontal insert, or scaler was selectively used in cases of deposits in areas that were difficult to access

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Quantitative evaluation of Streptococcus mutans

    Molecular methods Polymerase Chain Reaction - Quantitative Polymerase Chain Reaction (PCR-qPCR)

    Measured: T0 baseline, T1 4 months

  2. Quantitative evaluation of Selemonas sputigena

    Molecular methods Polymerase Chain Reaction - Quantitative Polymerase Chain Reaction (PCR-qPCR)

    Measured: T0 baseline, T1 4 months

Secondary outcomes (3)
  1. Plaque Control Record

    The Plaque Control Record (%) indicates the percentage of the tooth surface covered by bacterial plaque. The percentage was calculated by dividing the number of tooth surfaces with plaque by the number of areas examined and then multiplying the result by 100. Four surfaces were examined for each tooth: buccal, lingual/palatal, mesial, and distal surfaces. The highest value is 100% and it means that plaque is present on all the surfaces.

    Measured: T0 baseline, T1 4 months

  2. DMFT

    The DMFT is a caries prevalence index that refers to the presence of Decayed, Missing, Filled Teeth due to caries (Decayed, Missing, Filled Teeth). The individual value for the patient is the sum of D+M+F. The highest score is 32 and it shows the greatest value for this index.

    Measured: T0 baseline, T1 4 months

  3. Salivary ph

    To assess salivary pH, a specific pH reagent strip was moistened with the patient's saliva. After an appropriate waiting period, as indicated by the manufacturer of the saliva test, the color displayed by the strip was compared to that on the reference scale to read the result. The scale of pH is: <6,5 acid; 6,5-7,5 neutral; >7,5 alkaline.

    Measured: T0 baseline, T1 4 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jul 2025
  2. Study start16 Nov 2023
  3. Primary completion30 Jun 2025
  4. Study completionNov 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07091890
Sponsor's protocol ID
328CET
Status last verified
Jul 2025
First submitted
10 Jul 2025
Last updated
29 Jul 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Fluoride gel and Fluoride varnish in people with Topical Fluoride and Orthodontic Patients, run by Universita di Verona at 1 site in Italy.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 29 Jul 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Quantitative evaluation of Streptococcus mutans (time frame: T0 baseline, T1 4 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jul 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in